Community Job Board

Explore jobs at our portfolio companies
ImmTune Therapies
ImmTune Therapies


Stevenage, UK


Biotechnology · DeepTech · Health · Manufacturing


1 - 10 employees



founded in


CAR-T therapy is a form of cancer treatment that uses a chimeric antigen receptor (CAR) to target killer T-cells towards tumour cells in the body. The first marketed CAR-T therapies, Kymriah and Yescarta, have been able to cure over 60% of previously hopeless leukaemia cases. However, the method currently requires therapeutic cells to be modified and grown outside the body, which is a highly complex and expensive process. The production process results in cells of variable quality, and treatments priced in the £100,000s. In addition, these therapies currently only work well in blood cancers (less than 4% of total cases), and more effective cell products are needed to make an impact on other tumours. ImmTune Therapies is designing vectors that can deliver the CARs directly to T-cells inside the body. This will allow the body itself to develop these therapeutic cells; a process we expect to be considerably cheaper, and to produce more effective products. This will allow ImmTune to platform and empower the revolutionary cancer medicines of tomorrow.

Something looks off?
Open jobs at ImmTune Therapies
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.